C44.311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Codes should be selected from the table. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. by John Verhovshek, MA, CPC article does not apply to that Bill Type. The following ICD-10-CM codes support medical necessity and provide limited coverage for CPT codes: 11620, 11621, 11622, 11623, 11624, and 11626. Verrucous Carcinoma: Diagnosis, Treatment, Symptoms & Pathology ICD-10 code D04 for Carcinoma in situ of skin is a medical classification as listed by WHO under the range - Neoplasms . C44.02 Squamous cell carcinoma of skin of lip C44.12- Squamous cell carcinoma of skin of eyelid, including canthus End Users do not act for or on behalf of the CMS. For purpose of this exclusion, "the term 'usually' means more than 50 percent of the time for all Medicare beneficiaries who use the drug. However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. There are multiple ways to create a PDF of a document that you are currently viewing. D04.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. This Agreement will terminate upon notice if you violate its terms. PDF Appendix E1 - 2018 SEER Program Coding and Staging Manual Reportable CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in the LCD. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). hb```@( f p,&}5y5LJ"%%%3th/ $84C@1(6H(\Fed 6#V3gYq copied without the express written consent of the AHA. [*]Carcinoma in situ of skin of s [QUOTE="thomas7331, post: 478231, member: 5404"] "JavaScript" disabled. CMS and its products and services are not endorsed by the AHA or any of its affiliates. Squamous cell carcinoma (SCC) is common form of keratinocytic skin cancer, usually related to exposure to ultraviolet radiation from sunlight. Squamous cell carcinoma, skin of left breast; Squamous cell carcinoma, skin of right breast; ICD-10-CM C44.521 is grouped within Diagnostic Related Group(s) (MS-DRG v 40.0): 606 Minor skin disorders with mcc; 607 Minor skin disorders without mcc; Convert C44.521 to ICD-9-CM. 2023 ICD-10-CM Diagnosis Code C44.521 - ICD10Data.com determine from the record if the neoplasm is benign, in-situ, malignant, or of uncertain histologic behavior. This is the American ICD-10-CM version of D04.9 - other international versions of ICD-10 D04.9 may differ. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. Per the 2020 ICD-10 guidelines, 'consistent with D04.4 would be incorrect as this is documented neither [I]in situ [/I]nor as a carcinoma of the skin. Abnormal cells are found in the lower part of the epidermis (the outer layer of the skin). 625 0 obj <>/Filter/FlateDecode/ID[<300BF5E799812D49BBFB4D9A3883AA65>]/Index[604 32]/Info 603 0 R/Length 104/Prev 172627/Root 605 0 R/Size 636/Type/XRef/W[1 3 1]>>stream Carcinoma - Wikipedia M0: no clinical or radiographic evidence of distant metastasis. "JavaScript" disabled. Use of indoor UV tanning equipment increases a persons risk of developing squamous cell carcinoma by 67 percent. The views and/or positions "JavaScript" disabled. authorized with an express license from the American Hospital Association. In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice. Draft articles have document IDs that begin with "DA" (e.g., DA12345). 5th digit 1: Basal cell carcinoma of skin 5th digit 2: Squamous cell carcinoma of skin 5th digit 9: Other specific malignant neoplasm of skin : Kaposi Sarcoma (46) . Billing Skin []. A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. John Verhovshek, MA, CPC, is a contributing editor at AAPC. You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or Instructions for enabling "JavaScript" can be found here. Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled "I Accept". C44.22- Squamous cell carcinoma of skin of ear and external auricular canal Also, you can decide how often you want to get updates. The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. Absence of a Bill Type does not guarantee that the without the written consent of the AHA. Stage 0 includes: tis, n0, m0. An asterisk (*) indicates a Information. - C44.02 (squamous cell carcinoma of skin of lip) - 173.02 (squamous cell carcinoma of skin Please do not use this feature to contact CMS. Applications are available at the American Dental Association web site. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. The CPT code should reflect the knowledge, skill, time and effort that the provider invests in the excision of the lesion. Billing and Coding articles provide guidance for the related Local Coverage Determination (LCD) and assist providers in submitting correct claims for payment. Copyright © 2022, the American Hospital Association, Chicago, Illinois. that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes. You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. Use of CDT is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). PDF Coding Dermatology Procedures - AAPC The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. Subscribe to Codify by AAPC and get the code details in a flash. Request a Demo 14 Day Free Trial Buy Now Official Long Descriptor Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. The Table of Neoplasms should be used to identify the correct topography code. Privacy Policy | Terms & Conditions | Contact Us. 23. The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Consequently, solar UVR-induced skin cancers are among the most common forms of occupational malignancies that are potentially expected globally. Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. DISCLOSED HEREIN. You, your employees and agents are authorized to use CPT only as agreed upon with the AMA internally within your organization within the United States for the sole use by yourself, employees and agents. preparation of this material, or the analysis of information provided in the material. When billing for non-covered services, use the appropriate modifier. OPSCC cases were defined using the following International Classification of Disease for Oncology (ICD-O-3) site codes: base of tongue (C01.9 . (based on ajcc cancer staging). article does not apply to that Bill Type. All Rights Reserved. The responsibility for the content of this file/product is with CMS and no endorsement by the AMA is intended or implied. Treatment can involve surgical and nonsurgical methods. The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. Self-Administered Drug (SAD) Exclusion List articles list the CPT/HCPCS codes that are excluded from coverage under this category. Please note that if you choose to continue without enabling "JavaScript" certain functionalities on this website may not be available. C44.42 Squamous cell carcinoma of skin of scalp and neck This Agreement will terminate upon notice if you violate its terms. Note: Squamous cell carcinoma of the perianal skin (C445) is : not : . The 2023 edition of ICD-10-CM D04.9 became effective on October 1, 2022. Noninvasive can be used as a synonym for in situ, ICD-O-3 behavior code /2. endstream endobj 605 0 obj <. You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement. Risk of cutaneous squamous cell carcinoma due to occupational exposure CDT is a trademark of the ADA. Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The main histological types of NSCLC are adenocarcinoma, squamous cell and large cell carcinoma. 2023 ICD-10-CM Diagnosis Code D04.30: Carcinoma in situ of skin of Applicable FARS\DFARS Restrictions Apply to Government Use. icd 10 code for bone marrow edema right knee. For example, there is no way in ICD to distinguish between an adenocarcinoma of the lung and a squamous cell carcinoma of the lung: both would be coded to C34.9. will not infringe on privately owned rights. Very few histological types are identified in ICD. Morphology & Grade. Proper coding is C44.622 Squamous cell carcinoma of skin of right upper limb, including shoulder. All documentation must be maintained in the patient's medical record and made available to the contractor upon request. The code lists in the article help explain which services (procedures) the related LCD applies to, the diagnosis codes for which the service is covered, or for which the service is not considered reasonable and necessary and therefore not covered. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or Curettage and electrodessication (C and E). Reproduced with permission. Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. C and E treatment involves removing the surface of the skin cancer with a scraping instrument (curet) and then searing the base of the cancer with an electric needle. icd 10 code for bone marrow edema right knee. Create your account. Contractors may specify Bill Types to help providers identify those Bill Types typically Vulval intraepithelial neoplasia (VIN). Squamous intraepithelial lesion "JavaScript" disabled. These materials contain Current Dental Terminology (CDTTM), copyright© 2022 American Dental Association (ADA). Squamous cell carcinoma of skin of lip C44.09 . In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice. American Hospital Association ("AHA"), Carcinoma in situ of skin of eyelid, including canthus, Carcinoma in situ of skin of ear and external auricular canal, Carcinoma in situ of skin of other and unspecified parts of face, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of skin of upper limb, including shoulder, Carcinoma in situ of skin of lower limb, including hip. The AMA is a third party beneficiary to this Agreement. As a result, in ICD-10, five different categories of four characters each are needed to describe all lung neoplasms (see Figure 2). CPT is a trademark of the American Medical Association (AMA). squamous cell carcinoma in situ icd 10: The AMA assumes no liability for data contained or not contained herein. Absence of a Bill Type does not guarantee that the Check out the dx block of D04.4. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES ICD-10 Code for Carcinoma in situ of skin- D04- Codify by AAPC Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. Subscribe to Codify by AAPC and get the code details in a flash. These rules can be found i n the front of the ICD-O-3 code book. Verrucous carcinoma is a type of squamous cell carcinoma (SCC) that can develop in your gums and cheeks the oral cavity as well as your genitals and feet. MACs are Medicare contractors that develop LCDs and Articles along with processing of Medicare claims. Proper coding is C44.02Squamous cell carcinoma of skin of lip. This is the American ICD-10-CM version of C44.91 - other international versions of ICD-10 C44.91 may differ. complete information, CMS does not guarantee that there are no errors in the information displayed on this web site. To submit a comment or question to CMS, please use the Feedback/Ask a Question link available at the bottom In this context, annotation back-references refer to codes that contain: This is the American ICD-10-CM version of. Differences between ICD-O & ICD-10 | SEER Training This page displays your requested Article. Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). FAQ icd 10 code for basal cell carcinoma of nose What is the ICD 10 for basal cell carcinoma of skin? that coverage is not influenced by Bill Type and the article should be assumed to ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33818 - Excision of Malignant Skin Lesions, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, TRUNK, ARMS, OR LEGS; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, SCALP, NECK, HANDS, FEET, GENITALIA; EXCISED DIAMETER OVER 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.5 CM OR LESS, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 0.6 TO 1.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 1.1 TO 2.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 2.1 TO 3.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER 3.1 TO 4.0 CM, EXCISION, MALIGNANT LESION INCLUDING MARGINS, FACE, EARS, EYELIDS, NOSE, LIPS; EXCISED DIAMETER OVER 4.0 CM, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Unspecified malignant neoplasm of anal skin, Unspecified malignant neoplasm of skin of breast, Unspecified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Unspecified malignant neoplasm of skin of unspecified upper limb, including shoulder, Unspecified malignant neoplasm of skin of right upper limb, including shoulder, Unspecified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of unspecified upper limb, including shoulder, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of unspecified upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of unspecified upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Unspecified malignant neoplasm of skin of unspecified lower limb, including hip, Unspecified malignant neoplasm of skin of right lower limb, including hip, Unspecified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of skin of unspecified lower limb, including hip, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of unspecified lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of unspecified lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Unspecified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Malignant neoplasm of overlapping sites of vulva, Malignant neoplasm of other specified female genital organs, Malignant neoplasm of overlapping sites of female genital organs, Malignant neoplasm of overlapping sites of penis, Malignant neoplasm of head, face and neck, Secondary malignant neoplasm of genital organs, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of unspecified female genital organs, Carcinoma in situ of other female genital organs, Carcinoma in situ of unspecified male genital organs, Carcinoma in situ of other male genital organs, Malignant neoplasm of external lip, unspecified, Malignant neoplasm of upper lip, inner aspect, Malignant neoplasm of lower lip, inner aspect, Malignant neoplasm of lip, unspecified, inner aspect, Malignant neoplasm of commissure of lip, unspecified, Malignant neoplasm of overlapping sites of lip, Malignant neoplasm of dorsal surface of tongue, Malignant neoplasm of ventral surface of tongue, Malignant neoplasm of anterior two-thirds of tongue, part unspecified, Malignant neoplasm of overlapping sites of tongue, Malignant neoplasm of tongue, unspecified, Malignant neoplasm of anterior floor of mouth, Malignant neoplasm of lateral floor of mouth, Malignant neoplasm of overlapping sites of floor of mouth, Malignant neoplasm of floor of mouth, unspecified, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant neoplasm of submandibular gland, Malignant neoplasm of major salivary gland, unspecified, Malignant neoplasm of tonsillar pillar (anterior) (posterior), Malignant neoplasm of overlapping sites of tonsil, Malignant neoplasm of tonsil, unspecified, Malignant neoplasm of anterior surface of epiglottis, Malignant neoplasm of lateral wall of oropharynx, Malignant neoplasm of posterior wall of oropharynx, Malignant neoplasm of overlapping sites of oropharynx, Malignant neoplasm of oropharynx, unspecified, Malignant neoplasm of superior wall of nasopharynx, Malignant neoplasm of posterior wall of nasopharynx, Malignant neoplasm of lateral wall of nasopharynx, Malignant neoplasm of anterior wall of nasopharynx, Malignant neoplasm of overlapping sites of nasopharynx, Malignant neoplasm of nasopharynx, unspecified, Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect, Malignant neoplasm of posterior wall of hypopharynx, Malignant neoplasm of overlapping sites of hypopharynx, Malignant neoplasm of hypopharynx, unspecified, Malignant neoplasm of pharynx, unspecified, Malignant neoplasm of overlapping sites of lip, oral cavity and pharynx, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of overlapping sites, Unspecified malignant neoplasm of skin of lip, Other specified malignant neoplasm of skin of lip, Unspecified malignant neoplasm of skin of unspecified eyelid, including canthus, Unspecified malignant neoplasm of skin of right upper eyelid, including canthus, Unspecified malignant neoplasm of skin of right lower eyelid, including canthus, Unspecified malignant neoplasm of skin of left upper eyelid, including canthus, Unspecified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of unspecified eyelid, including canthus, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of unspecified eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Sebaceous cell carcinoma of skin of unspecified eyelid, including canthus, Sebaceous cell carcinoma of skin of right upper eyelid, including canthus, Sebaceous cell carcinoma of skin of right lower eyelid, including canthus, Sebaceous cell carcinoma of skin of left upper eyelid, including canthus, Sebaceous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of unspecified eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Unspecified malignant neoplasm of skin of unspecified ear and external auricular canal, Unspecified malignant neoplasm of skin of right ear and external auricular canal, Unspecified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of unspecified ear and external auricular canal, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of unspecified ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of unspecified ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Unspecified malignant neoplasm of skin of unspecified part of face, Unspecified malignant neoplasm of skin of nose, Unspecified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of unspecified parts of face, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of unspecified parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of unspecified parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Unspecified malignant neoplasm of overlapping sites of skin, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Carcinoma in situ of oral cavity, unspecified site, Carcinoma in situ of labial mucosa and vermilion border, Carcinoma in situ of gingiva and edentulous alveolar ridge, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Some older versions have been archived.

Who Inherited Phyllis Mcguire Estate, Articles I